Plutonian Acquisition Corp. II quarterly report, Q2 FY2027

Plutonian Acquisition Corp. II — Form 10-Q Summary

Reporting period: Quarter and six months ended August 31, 2026; filed October 15, 2026. Plutonian is a Cayman Islands blank-check company seeking a business combination, with a stated focus on Asia-Pacific targets excluding companies based in or principally operating in Greater China. It had not commenced operating activities by period-end and has no operating revenue.

Financial performance and position

MetricThree months ended Aug. 31, 2026Six months ended Aug. 31, 2026
General and administrative expenses$259,473$365,491
Trust investment interest income$967,381$1,294,747
Total other income, including bank interest$971,046$1,298,741
Net income$711,573$933,250
  • Prior-year comparable periods reported net losses of $16,366 for the quarter and $61,790 for six months. The 2026 profit chiefly reflects interest earned on IPO proceeds held in trust, rather than operating performance. Operating margins are not meaningful because the company has no operating revenue.
  • At August 31, 2026, total assets were $109.62 million, including $109.33 million in trust investments and $270,975 in cash outside the trust. Working capital was $218,245.
  • Total liabilities were $72,980: $69,500 of accounts payable and accrued expenses and $3,480 due to a related party. The $200,000 sponsor promissory note outstanding at February 28, 2026 was repaid after the IPO. No working capital loans were outstanding.
  • Six-month cash flows: $314,349 used in operations, $108.04 million used for trust investments, and $108.57 million provided by financing. Cash increased by $221,702 to $270,975.
  • The 10.75 million public shares are classified as subject to possible redemption at $10.17 per share, totaling $109.33 million in temporary equity. The trust held $108.04 million when funded and earned interest thereafter.

Material changes and developments

  • The company completed its IPO on April 29, 2026, selling 10 million units at $10 each, and the underwriters partially exercised the over-allotment option for another 750,000 units on May 5. It also sold 217,800 private placement units to its sponsor. In total, $108.04 million was placed in trust.
  • On September 3, 2026, after quarter-end, the company agreed to a business combination with NT1 Pty Ltd. NT1 shareholders would receive 50 million shares of a newly formed Purchaser, stated as $500 million of consideration at $10 per share, subject to potential adjustment based on independent valuation and technical reports. Plutonian would become a wholly owned subsidiary of Purchaser; existing Plutonian shares, units and rights would convert into substantially equivalent Purchaser securities.
  • The proposed transaction remains conditional on shareholder and regulatory approvals, including applicable antitrust and Australian foreign investment approvals, and other customary conditions. It may be terminated in specified circumstances, including if not completed by June 30, 2027, unless extended. Certain material-breach circumstances carry a $500,000 breakup fee plus specified expenses.
  • Compared with the prior-year periods, 2026 reflects the IPO, trust assets and related interest income; 2025 had no trust investment income.

Outlook, risks and unusual items

  • Management states that cash and other resources outside the trust are insufficient to sustain operations for one year from issuance of the financial statements. The filing identifies substantial doubt about the company’s ability to continue as a going concern until a business combination or required liquidation. Additional sponsor or affiliate funding may be available, but is not assured.
  • The company’s stated business-combination deadline is April 27, 2027, unless extended. If no combination is completed within the applicable period, it must cease operations, redeem public shares from the trust, and liquidate. Rights expire worthless if no combination is completed.
  • Management expects continued deal-search, due-diligence and public-company costs. The company pays its sponsor $10,000 monthly for administrative services; $40,000 was accrued and unpaid at August 31, 2026.
  • The sponsor’s trust-protection indemnity is limited and may not be collectible: the company has not required a reserve and has not verified the sponsor’s ability to pay. Trust funds may also face creditor claims that could have priority over public shareholders.
  • Management cites trade tensions, tariffs, global conflicts, market volatility, sanctions, supply-chain interruptions and cyberattacks as potential risks. No material litigation was reported. Disclosure controls were assessed as effective, with no material change in internal control reported for the quarter.

Important facts for investors to verify

  • Progress toward NT1 transaction conditions, including shareholder, regulatory, Australian foreign investment and antitrust approvals; any changes to consideration or closing timetable.
  • Available cash outside the trust, expected transaction and operating costs, and whether additional funding will be needed or obtained.
  • The April 27, 2027 business-combination deadline and any proposed extension, alongside the agreement’s separate June 30, 2027 termination date.
  • Trust balance, redemption value, public-share redemptions and the dilution effects of rights, founder-share conversion and the proposed equity incentive plan of up to 10% of Purchaser’s fully diluted capitalization.
  • The company’s going-concern warning and the sponsor’s capacity to meet its stated indemnity obligations.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.